UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.48B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$690M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$588M |
| 4 |
Truist Financial
TFC
|
+$532M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.3B |
| 2 |
Alibaba
BABA
|
+$771M |
| 3 |
AABA
Altaba Inc
AABA
|
+$759M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$503M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.82% |
| 2 | Financials | 7.38% |
| 3 | Healthcare | 6.65% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Industrials | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
PUT
Dollar General
DG
$28.1B
| $11.5M | ﹤0.01% |
74,000
-300
| -0.4% | -$47.6K |
|
|
PARA
1827
PUT
DELISTED
Paramount Global Class B
PARA
| $11.5M | ﹤0.01% |
274,600
-250,000
| -48% | -$9.68M |
|
|
AERI
1828
DELISTED
Aerie Pharmaceuticals
AERI
| $11.5M | ﹤0.01% |
+476,557
| New | +$9.87M |
|
1829
Tenet Healthcare
THC
$20.4B
| $11.5M | ﹤0.01% |
302,746
+235,134
| +348% | +$7.04M |
|
|
BPYU
1830
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $11.5M | ﹤0.01% |
624,182
-64,981
| -9% | -$1.23M |
|
1831
PUT
American Airlines Group
AAL
$11B
| $11.5M | ﹤0.01% |
400,000
+150,000
| +60% | +$4.28M |
|
1832
Selective Insurance
SIGI
$5.76B
| $11.5M | ﹤0.01% |
175,882
+69,343
| +65% | +$4.8M |
|
1833
Open Text
OTEX
$6.41B
| $11.5M | ﹤0.01% |
260,035
+88,064
| +51% | +$3.7M |
|
1834
CALL
Humana
HUM
$43.5B
| $11.4M | ﹤0.01% |
31,200
+27,500
| +743% | +$8.72M |
|
1835
WisdomTree US High Dividend Fund
DHS
$1.59B
| $11.4M | ﹤0.01% |
148,790
+975
| +0.7% | +$73.5K |
|
1836
iShares Morningstar Value ETF
ILCV
$1.35B
| $11.4M | ﹤0.01% |
194,810
-1,882
| -1% | -$107K |
|
1837
LGI Homes
LGIH
$1.43B
| $11.4M | ﹤0.01% |
161,308
+38,793
| +32% | +$2.95M |
|
|
DHC
1838
Diversified Healthcare Trust
DHC
$2.13B
| $11.4M | ﹤0.01% |
1,348,869
+194,079
| +17% | +$1.64M |
|
1839
JetBlue
JBLU
$2.42B
| $11.4M | ﹤0.01% |
608,006
-94,410
| -13% | -$1.75M |
|
|
HPP
1840
Hudson Pacific Properties
HPP
$758M
| $11.4M | ﹤0.01% |
43,149
+10,871
| +34% | +$2.68M |
|
1841
Burlington
BURL
$23.2B
| $11.4M | ﹤0.01% |
49,843
-1,148
| -2% | -$240K |
|
1842
State Street SPDR ICE Preferred Securities ETF
PSK
$688M
| $11.4M | ﹤0.01% |
258,170
+34,541
| +15% | +$1.52M |
|
1843
KBR
KBR
$4.77B
| $11.4M | ﹤0.01% |
372,477
+157,833
| +74% | +$4.44M |
|
1844
Ingersoll Rand
IR
$34.7B
| $11.3M | ﹤0.01% |
308,670
-11,208
| -4% | -$368K |
|
|
EFOR
1845
Everforth Inc
EFOR
$1.26B
| $11.3M | ﹤0.01% |
159,357
+68,793
| +76% | +$4.49M |
|
1846
iShares Global Consumer Staples ETF
KXI
$1.06B
| $11.3M | ﹤0.01% |
203,821
+46,632
| +30% | +$2.55M |
|
1847
CALL
BP
BP
$109B
| $11.3M | ﹤0.01% |
299,200
-1,500
| -0.5% | -$57K |
|
|
PRAH
1848
DELISTED
PRA Health Sciences, Inc.
PRAH
| $11.3M | ﹤0.01% |
101,568
+35,000
| +53% | +$3.6M |
|
|
IBDQ
1849
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
| $11.3M | ﹤0.01% |
434,522
+27,249
| +7% | +$705K |
|
1850
CALL
NetEase
NTES
$83.6B
| $11.2M | ﹤0.01% |
183,360
-44,890
| -20% | -$2.63M |
|
Similar funds
UBS Group's Q4 2019 Portfolio in Review
As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q4 2019 filing shows 808 new, 4,307 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.
By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
- UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
- UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
- UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
- UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
- UBS Group opened 808 new positions and closed 688 in Q4 2019.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.
Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.